BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19129457)

  • 21. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
    Lusso P; Cocchi F; Balotta C; Markham PD; Louie A; Farci P; Pal R; Gallo RC; Reitz MS
    J Virol; 1995 Jun; 69(6):3712-20. PubMed ID: 7745720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein.
    Huang W; Toma J; Fransen S; Stawiski E; Reeves JD; Whitcomb JM; Parkin N; Petropoulos CJ
    J Virol; 2008 Jun; 82(11):5584-93. PubMed ID: 18353956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.
    Puffer BA; Pöhlmann S; Edinger AL; Carlin D; Sanchez MD; Reitter J; Watry DD; Fox HS; Desrosiers RC; Doms RW
    J Virol; 2002 Mar; 76(6):2595-605. PubMed ID: 11861825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates.
    Vaine M; Duenas-Decamp M; Peters P; Liu Q; Arthos J; Wang S; Clapham P; Lu S
    J Virol; 2011 May; 85(10):4927-36. PubMed ID: 21411542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.
    Dunfee RL; Thomas ER; Gorry PR; Wang J; Taylor J; Kunstman K; Wolinsky SM; Gabuzda D
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15160-5. PubMed ID: 17015824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
    Visseaux B; Hurtado-Nedelec M; Charpentier C; Collin G; Storto A; Matheron S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D;
    J Infect Dis; 2012 Jan; 205(1):111-20. PubMed ID: 22140264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop.
    Duenas-Decamp MJ; Peters P; Burton D; Clapham PR
    J Virol; 2008 Jun; 82(12):5807-14. PubMed ID: 18385254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
    J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism.
    Sharpless NE; O'Brien WA; Verdin E; Kufta CV; Chen IS; Dubois-Dalcq M
    J Virol; 1992 Apr; 66(4):2588-93. PubMed ID: 1548785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
    Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
    Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4.
    Zhang H; Tully DC; Zhang T; Moriyama H; Thompson J; Wood C
    Virology; 2010 Nov; 407(1):68-79. PubMed ID: 20797755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity.
    Bhakta SJ; Shang L; Prince JL; Claiborne DT; Hunter E
    Retrovirology; 2011 May; 8():37. PubMed ID: 21569545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V3-independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate.
    Kim FM; Kolson DL; Balliet JW; Srinivasan A; Collman RG
    J Virol; 1995 Mar; 69(3):1755-61. PubMed ID: 7853514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.
    Sterjovski J; Churchill MJ; Ellett A; Gray LR; Roche MJ; Dunfee RL; Purcell DF; Saksena N; Wang B; Sonza S; Wesselingh SL; Karlsson I; Fenyo EM; Gabuzda D; Cunningham AL; Gorry PR
    Retrovirology; 2007 Dec; 4():89. PubMed ID: 18076768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop.
    Gharu L; Ringe R; Pandey S; Paranjape R; Bhattacharya J
    Virus Res; 2009 Sep; 144(1-2):306-14. PubMed ID: 19409946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.
    Gonzalez-Perez MP; Peters PJ; O'Connell O; Silva N; Harbison C; Cummings Macri S; Kaliyaperumal S; Luzuriaga K; Clapham PR
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.
    Dunfee RL; Thomas ER; Gabuzda D
    Retrovirology; 2009 Jul; 6():69. PubMed ID: 19619305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.
    Zhang PF; Bouma P; Park EJ; Margolick JB; Robinson JE; Zolla-Pazner S; Flora MN; Quinnan GV
    J Virol; 2002 Jan; 76(2):644-55. PubMed ID: 11752155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R5 Macrophage-Tropic HIV-1 in the Male Genital Tract.
    Bednar MM; Hauser BM; Ping LH; Dukhovlinova E; Zhou S; Arrildt KT; Hoffman IF; Eron JJ; Cohen MS; Swanstrom R
    J Virol; 2015 Oct; 89(20):10688-92. PubMed ID: 26223642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.